Aucta Pharmaceuticals, Inc.
🇺🇸United States
Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex
Phase 2
Terminated
- Conditions
- Tuberous SclerosisAngiofibroma of Face
- Interventions
- First Posted Date
- 2017-12-06
- Last Posted Date
- 2023-03-30
- Lead Sponsor
- Aucta Pharmaceuticals, Inc
- Target Recruit Count
- 24
- Registration Number
- NCT03363763
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸LeBonheur Children's Hospital, Memphis, Tennessee, United States
🇺🇸Translational Genomics Research, Phoenix, Arizona, United States
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects
- First Posted Date
- 2017-08-04
- Last Posted Date
- 2018-06-27
- Lead Sponsor
- Aucta Pharmaceuticals, Inc
- Target Recruit Count
- 40
- Registration Number
- NCT03239353
- Locations
- 🇦🇺
Linear Clinical Research Ltd, Nedlands, Western Australia, Australia
© Copyright 2025. All Rights Reserved by MedPath